Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group.
Blood Adv
; 7(14): 3735-3738, 2023 07 25.
Article
in En
| MEDLINE
| ID: mdl-37067945
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunomodulating Agents
/
Lymphoma
Limits:
Humans
Language:
En
Journal:
Blood Adv
Year:
2023
Type:
Article
Affiliation country:
France